CRISPR Therapeutics AG
Closed
SectorHealthcare
59 -0.77
Overview
Share price change
24h
Min
58.51
Max
63.41
Income | 7.7M -123M |
|---|---|
Sales | 594K 1.5M |
EPS | -1.28 |
Profit margin | -8,431.481 |
Employees | 393 |
EBITDA | 31M -118M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +19.32% upside |
Next Earnings | 31 lip 2026 |
|---|
Market Cap | 418M 5.3B |
|---|---|
Previous open | 59.77 |
Previous close | 59 |
News Sentiment
By Acuity
50%
50%
164 / 342 Ranking in Healthcare
CRISPR Therapeutics AG Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
CRISPR Therapeutics AG Forecast
Price Target
By TipRanks
12 Months Forecast
Average 73.85 USD 19.32%
High 110 USD
Low 45 USD
Based on 14 Wall Street analysts offering 12 month price targets forCRISPR Therapeutics AG - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$